JP2008534672A - 抗菌剤としての7−フルオロ−1,3−ジヒドロ−インドール−2−オンオキサゾリジノン - Google Patents

抗菌剤としての7−フルオロ−1,3−ジヒドロ−インドール−2−オンオキサゾリジノン Download PDF

Info

Publication number
JP2008534672A
JP2008534672A JP2008504870A JP2008504870A JP2008534672A JP 2008534672 A JP2008534672 A JP 2008534672A JP 2008504870 A JP2008504870 A JP 2008504870A JP 2008504870 A JP2008504870 A JP 2008504870A JP 2008534672 A JP2008534672 A JP 2008534672A
Authority
JP
Japan
Prior art keywords
fluoro
compound
dihydro
indol
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008504870A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008534672A5 (cg-RX-API-DMAC7.html
Inventor
フェドー ゴーディブ ミカイル
プラサド ヴェンカタ ナゲンドラ ジョスユラ ヴァラ
ウェイン ルエフル ゲーリー
Original Assignee
ファルマシア アンド アップジョン カンパニー リミテッド ライアビリティ カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファルマシア アンド アップジョン カンパニー リミテッド ライアビリティ カンパニー filed Critical ファルマシア アンド アップジョン カンパニー リミテッド ライアビリティ カンパニー
Publication of JP2008534672A publication Critical patent/JP2008534672A/ja
Publication of JP2008534672A5 publication Critical patent/JP2008534672A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2008504870A 2005-04-06 2006-03-27 抗菌剤としての7−フルオロ−1,3−ジヒドロ−インドール−2−オンオキサゾリジノン Withdrawn JP2008534672A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66871505P 2005-04-06 2005-04-06
US68403305P 2005-05-24 2005-05-24
PCT/IB2006/000954 WO2006106427A1 (en) 2005-04-06 2006-03-27 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents

Publications (2)

Publication Number Publication Date
JP2008534672A true JP2008534672A (ja) 2008-08-28
JP2008534672A5 JP2008534672A5 (cg-RX-API-DMAC7.html) 2009-05-14

Family

ID=36636389

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008504870A Withdrawn JP2008534672A (ja) 2005-04-06 2006-03-27 抗菌剤としての7−フルオロ−1,3−ジヒドロ−インドール−2−オンオキサゾリジノン

Country Status (21)

Country Link
US (1) US7435751B2 (cg-RX-API-DMAC7.html)
EP (1) EP1869030A1 (cg-RX-API-DMAC7.html)
JP (1) JP2008534672A (cg-RX-API-DMAC7.html)
KR (1) KR20070108938A (cg-RX-API-DMAC7.html)
AP (1) AP2007004172A0 (cg-RX-API-DMAC7.html)
AR (1) AR053839A1 (cg-RX-API-DMAC7.html)
AU (1) AU2006231919A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0610533A2 (cg-RX-API-DMAC7.html)
CA (1) CA2603899A1 (cg-RX-API-DMAC7.html)
CR (1) CR9417A (cg-RX-API-DMAC7.html)
DO (1) DOP2006000080A (cg-RX-API-DMAC7.html)
GT (1) GT200600133A (cg-RX-API-DMAC7.html)
IL (1) IL186119A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007012386A (cg-RX-API-DMAC7.html)
NL (1) NL1031525C2 (cg-RX-API-DMAC7.html)
NO (1) NO20075505L (cg-RX-API-DMAC7.html)
PE (1) PE20061301A1 (cg-RX-API-DMAC7.html)
TN (1) TNSN07373A1 (cg-RX-API-DMAC7.html)
TW (1) TW200716101A (cg-RX-API-DMAC7.html)
UY (1) UY29452A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006106427A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080262056A1 (en) * 2004-08-06 2008-10-23 Pfizer Inc Oxindole Oxazolidinones as Antibacterial Agents
KR100891485B1 (ko) 2007-10-29 2009-04-02 주식회사 만도 디스크 브레이크의 주차브레이크 장치
US20090124737A1 (en) * 2007-11-12 2009-05-14 Eastman Chemical Company Acrylic plastisol viscosity reducers

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2157934T3 (es) 1988-09-15 2001-09-01 Upjohn Co Fenil-5-beta-amidometiloxazolidin-2-onas sustituidas con nitrogeno en la posicion 3.
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
DE4425613A1 (de) 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
DE4425612A1 (de) 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
US6015429A (en) * 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
DE19649095A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue Heteroaryl-Oxazolidinone
DE19604223A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
CA2318969A1 (en) 1998-01-23 1999-07-29 Mikhail F. Gordeev Oxazolidinone combinatorial libraries, compositions and methods of preparation
DE69912264T2 (de) 1998-04-14 2004-07-22 Samsung Fine Chemicals Co., Ltd. Verfahren zur herstellung chiraler (s)-2,3-disubstituierter 1-propylamin-derivate
AU1379900A (en) 1998-11-17 2000-06-05 Bayer Aktiengesellschaft Novel substituted phenyloxazolidone derivatives
WO2000032599A1 (en) 1998-11-27 2000-06-08 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality
EP1181288B1 (en) 1999-05-27 2003-07-30 PHARMACIA & UPJOHN COMPANY Bicyclic oxazolidinones as antibacterial agent
ATE321024T1 (de) 2000-10-17 2006-04-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonverbindungen
DE60212959T2 (de) 2001-04-07 2007-02-15 Astrazeneca Ab Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika
ATE374463T1 (de) 2001-04-20 2007-10-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonen
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7012088B2 (en) * 2003-02-24 2006-03-14 Pharmacia & Upjohn Company Indolone oxazolidinones and derivatives thereof
US20080262056A1 (en) * 2004-08-06 2008-10-23 Pfizer Inc Oxindole Oxazolidinones as Antibacterial Agents

Also Published As

Publication number Publication date
CA2603899A1 (en) 2006-10-12
MX2007012386A (es) 2007-11-07
US7435751B2 (en) 2008-10-14
WO2006106427A8 (en) 2007-12-06
CR9417A (es) 2007-12-04
NL1031525C2 (nl) 2007-01-30
KR20070108938A (ko) 2007-11-13
GT200600133A (es) 2006-11-29
WO2006106427A1 (en) 2006-10-12
TNSN07373A1 (fr) 2009-03-17
AR053839A1 (es) 2007-05-23
IL186119A0 (en) 2008-01-20
PE20061301A1 (es) 2007-02-09
NO20075505L (no) 2007-10-31
BRPI0610533A2 (pt) 2010-06-29
NL1031525A1 (nl) 2006-10-09
US20060229349A1 (en) 2006-10-12
DOP2006000080A (es) 2006-12-15
AU2006231919A1 (en) 2006-10-12
TW200716101A (en) 2007-05-01
AP2007004172A0 (en) 2007-10-31
UY29452A1 (es) 2006-11-30
EP1869030A1 (en) 2007-12-26

Similar Documents

Publication Publication Date Title
EP1470123A1 (en) Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, related compositions and methods
EP1899331B1 (en) Homomorpholine oxazolidinones as antibacterial agents
US7435751B2 (en) 7-Fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
US20080262056A1 (en) Oxindole Oxazolidinones as Antibacterial Agents
JP2009500389A (ja) 抗菌剤としてのアゼチジンおよびシクロブタンを含むオキサゾリジノンカルボキサミド
JP2008521790A (ja) 抗菌剤としてのチアゼピンオキサゾリジノン
US20060229348A1 (en) Oxindole oxazolidinone as antibacterial agent
CN101155806A (zh) 作为抗菌剂的羟吲哚唑烷酮
JP2009526036A (ja) 抗菌剤としてのオキシインドールを含有するオキサゾリジノン
JP2009525318A (ja) 抗菌剤としてのベンズイソオキサゾールオキサゾリジノン
CN101155805A (zh) 作为抗菌剂的7-氟-1,3-二氢-吲哚-2-酮唑烷酮
KR20070030952A (ko) 항바이러스제로서 옥신돌을 함유하는 옥사졸리딘온
JP2008521792A (ja) 抗菌薬としてのジアゼピンオキサゾリジノン
HK1104294A (en) Oxazolidinones containing oxindoles as antibacterial agents

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090318

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090318

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20100712